Natural history of mild-moderate pulmonary hypertension and the risk factors for severe pulmonary hypertension in scleroderma.
about
Scleroderma lung diseaseSystemic sclerosis-associated pulmonary arterial hypertensionSaudi Guidelines on the Diagnosis and Treatment of Pulmonary Hypertension: Pulmonary arterial hypertension associated with connective tissue diseasesLung involvement in systemic sclerosis.Pulmonary arterial hypertension associated with systemic sclerosis.Connective tissue disease-associated pulmonary arterial hypertension.Late-age onset systemic sclerosis.Dynamics of calcitonin gene-related peptide-like cells changes in the lungs of two-kidney, one-clip rats.Subspecificities of anticentromeric protein A antibodies identify systemic sclerosis patients at higher risk of pulmonary vascular disease.Pulmonary arterial hypertension in connective tissue diseases.Baseline characteristics and follow-up in patients with normal haemodynamics versus borderline mean pulmonary arterial pressure in systemic sclerosis: results from the PHAROS registry.Antibodies recognising sulfated carbohydrates are prevalent in systemic sclerosis and associated with pulmonary vascular diseaseCardiac manifestations of rheumatological conditions: a narrative reviewPulmonary Arterial Hypertension-A Deadly Complication of Systemic Sclerosis.Changes in estimated right ventricular systolic pressure predict mortality and pulmonary hypertension in a cohort of scleroderma patients.Therapies for scleroderma-related pulmonary arterial hypertensionRelationship of main pulmonary artery diameter to pulmonary arterial pressure in scleroderma patients with and without interstitial fibrosis.Risk of Digital Vascular Events in Scleroderma Patients Who Have Both Anticentromere and Anti-Interferon-Inducible Protein 16 Antibodies.Systemic sclerosis-associated pulmonary arterial hypertension.
P2860
Q33919119-4C8CA6F0-FBA4-49CA-AE03-6C2F95FB0123Q33950086-C5FFB7B1-D4D9-4768-ACFA-88E4E63C7360Q33965825-A637C9AF-B463-43EA-BAA3-C65F77A735A7Q34732817-ACB16532-E5C9-4CCC-B9DF-26246DEAE03FQ35002423-397E2D50-02C8-4A5D-840C-62BB68A8FA22Q35029607-8FE41825-BBFD-4312-91FC-7E2C239CBCC4Q35106951-26135FEE-6FD4-4462-904E-C28787144657Q35959643-4CBCD363-4E1E-46B5-9502-3954D0FF7A4DQ36060142-C5BAA492-CD6D-4378-9621-B54875EFDB7EQ36075852-35E00421-33AE-4858-9B39-72AA2E4D453DQ36098875-7AFE3FFC-85CE-4536-9AB2-1E24644A02E9Q36130814-6B338ED7-D439-489A-9170-8C8CC63CB896Q36355415-0DE030DF-F703-4B46-A92C-979816F8ADC0Q36795578-92BB52AA-2FF2-40F7-A764-14B7378E425BQ37340271-19A844C4-7CD7-418E-8BDB-79CF3A74D437Q37364799-408AC15C-1ABC-4E86-A11F-4196668BC392Q37647966-A2EA08AA-BF67-400F-8D9C-2138A1BA9C7FQ40387800-7E8A9948-4915-41F2-9A7F-160AA618B6DFQ55309547-E129DF1B-8B33-43C6-AD75-AEBCB2E16035
P2860
Natural history of mild-moderate pulmonary hypertension and the risk factors for severe pulmonary hypertension in scleroderma.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
2006年學術文章
@zh-hant
name
Natural history of mild-modera ...... y hypertension in scleroderma.
@en
Natural history of mild-modera ...... y hypertension in scleroderma.
@nl
type
label
Natural history of mild-modera ...... y hypertension in scleroderma.
@en
Natural history of mild-modera ...... y hypertension in scleroderma.
@nl
prefLabel
Natural history of mild-modera ...... y hypertension in scleroderma.
@en
Natural history of mild-modera ...... y hypertension in scleroderma.
@nl
P2093
P1476
Natural history of mild-modera ...... ry hypertension in scleroderma
@en
P2093
Barbara White
Betty Chang
Fredrick M Wigley
Lionel Schachna
Robert A Wise
P304
P407
P577
2006-02-01T00:00:00Z